Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial

Published:2018-09 Issue: Volume:199 Page:52-61
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

He Xiao,Ai Shanmu,Guo Wei,Yang Yi,Wang Zhengguo,Jiang Dongpo,Xu Xiang^ORCID

Funder

National Nature Science Foundation of China

China Postdoctoral Science Foundation

Chongqing Academician

Nature Scientific Foundation of Chongqing

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference33 articles.

1. Sepsis: a new hypothesis for pathogenesis of the disease process;Bone;Chest,1997

2. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 study investigators;Angus;JAMA,2000

3. Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies;Lyle;Ann N Y Acad Sci,2014

4. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study;Rangel-Frausto;JAMA,1995

5. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin;Annane;JAMA,2000

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment;International Journal of Molecular Sciences;2024-07-05

2. Immunotherapy in the context of sepsis-induced immunological dysregulation;Frontiers in Immunology;2024-05-21

3. Advancing cell-based therapy in sepsis: An anesthesia outlook;Chinese Medical Journal;2024-05-06

4. Antimicrobial peptide LL37 and regulatory T cell associated with late-onset sepsis in very preterm infants;iScience;2024-05

5. Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis;Frontiers in Immunology;2024-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3